港股異動丨錦欣生殖(01951.HK)放量大漲6% 回購疊加機構唱好
格隆匯6月29日丨錦欣生殖(01951.HK)放量急升至6%,報10.88港元,暫成交1.2億港元,最新總市值264.3億港元。錦欣生殖6月23日回購38.50萬股,耗資128.77萬港元。據瞭解,公司近三個月累計回購股份數為526.70萬股,佔公司已發行股本的0.22%。招商證券(香港)日前指出,基於錦欣生殖的行業領先地位和潛在的外延式擴張機會,繼續維持買入評級,目標價13港元。另外,公司管理層表示4月份開始,四川和深圳輔助生殖市場的初診開始復甦,且良好的恢復態勢在5-6月份仍然持續。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.